- Two of the world’s leading healthcare-focused investment institutions will join forces to create the largest asset management platform dedicated to healthcare investments globally, with combined assets under management (AUM) exceeding $21 billion.
- The combined platform will cover North America, Europe, and the Asia-Pacific region, which together account for approximately 90% of global healthcare R&D spending.
- The combined platform will bring together over 200 professionals across 13 offices worldwide, helping portfolio companies achieve global expansion and offering investors access to high-growth healthcare markets around the world.
London and SingaporeMay 20, 2026 /PRNewswire/ — C-Bridge Capital, a leading Asia-based asset manager specializing in healthcare investments, and Global Healthcare Opportunities (GHO), a leading European healthcare-focused investment firm, today announced that they have signed a merger agreement to jointly establish the world’s largest healthcare investment asset management platform. The combined platform will have assets under management (AUM) exceeding $21 billion.
This merger brings together two leading investment institutions with a long-standing focus on the healthcare sector. Both share a common mission to drive the global development of healthcare services toward greater quality, efficiency, and accessibility. The combined platform will have 13 offices across North America, Europe, and the Asia-Pacific region, with over 200 investment and operations professionals. These three regions collectively account for approximately 90% of global healthcare R&D spending. Leveraging a broader global footprint, network, and resource synergies, the combined platform will be better positioned to capture structural growth opportunities driven by innovation.
C-Bridge Capital and GHO both uphold a long-established entrepreneurial spirit and founder culture, complemented by extensive investment and industrial operations experience, making them highly complementary. The combined platform will further empower the founders and management teams of portfolio companies, supporting them in accelerating the development and global expansion of cutting-edge healthcare solutions across areas such as biopharmaceuticals, medical devices, life science tools and diagnostics, healthcare infrastructure, and healthcare information technology. At the same time, the combined platform will offer investors more diverse healthcare and life science investment opportunities across asset classes, including private equity, private credit, pharmaceutical royalty investments, and real estate.
In terms of global capabilities, portfolio companies of GHO in North America and Europe will leverage the combined platform to strengthen their local presence and operational capabilities in the Asia-Pacific region. As one of the most dynamic regions for global healthcare innovation, Asia-Pacific has become a key growth frontier for many healthcare companies pursuing global expansion. Meanwhile, portfolio companies of C-Bridge Capital will benefit from the combined platform’s global resource network and local operational support to pursue global development more robustly.
Both institutions have long been deeply engaged in healthcare investment, maintaining long-term, close collaborations with global investors and accumulating over a decade of investment and value-creation experience. Existing funds and portfolio companies of both parties will continue to be managed by their original investment teams, with investment strategies and governance structures remaining unchanged.
The combined platform will be managed by an experienced team comprising founders from both C-Bridge Capital and GHO. Fu Wei, CEO of C-Bridge Capital, will serve as Co-CEO alongside Mike Mortimer, Managing Partner and Co-Founder of GHO Capital. Andrea Ponti and Alan MacKay will assume board responsibilities in financial oversight and corporate governance, respectively. The core management teams of both parties will continue to be deeply involved in the daily operations and management of the platform.
Fu Wei and Dr. Lady Mireille Gillings, Vice Chairman and Co-Founder of GHO Capital, will jointly serve as Co-Chairs of the Board.
Fu Wei commented: “This merger will more closely connect the world’s leading healthcare companies and innovation capabilities with the most mature and largest markets and capital systems globally. By integrating the complementary strengths of Asia-Pacific, North America, and Europe, we will further enhance global synergies. By jointly building the world’s largest healthcare-focused asset management platform, we are committed to improving access to universal healthcare, driving innovation, enhancing efficiency, and supporting the growth and scaling of portfolio companies and their management teams to more effectively meet unmet medical needs worldwide.”
Mike Mortimer commented: “This merger will further solidify our expertise in the healthcare sector, expand our global footprint, and enhance our value-creation capabilities, helping portfolio companies strengthen their competitiveness and achieve sustained growth in a rapidly evolving global healthcare market. By integrating regional experience and platform capabilities, we will continue our shared commitment to identifying and nurturing industry-leading companies, further unlocking synergies to deliver robust returns for investors and drive improvements in global health and well-being.”
Dr. Lady Mireille Gillings commented: “This powerful combination marks a new phase of development for both parties. We have always been dedicated to seizing innovation-driven, high-growth healthcare opportunities to make healthcare services better, more efficient, and more accessible. Particularly against the backdrop of artificial intelligence rapidly reshaping the healthcare and life sciences industries, the application of AI in this field will remain a key development direction. With the Asia-Pacific region accounting for 40% of global healthcare R&D spending, deepening our local presence in this region is both a natural extension of our strategy and highly complementary to our existing capabilities.”
The management team of the combined platform will also be further strengthened. Dr. Michael Keyoung and Kang Haihua of C-Bridge Capital will continue to oversee the overall strategy and business development of the private credit and healthcare infrastructure platforms, respectively, while Stuart Quin and Edward de Nor will manage GHO’s investment team.
The merger is expected to be completed in early 2027, subject to customary closing conditions and regulatory approvals. Prior to completion, C-Bridge Capital and GHO will continue to operate independently, managing their respective funds in accordance with their established investment strategies.
Goldman Sachs and Morgan Stanley are serving as financial advisors, and Kirkland & Ellis is serving as legal advisor for the transaction.